NCT07069036View on ClinicalTrials.gov

A Study to Evaluate Single and Multiple Doses of SEP-631 in Healthy Adult Volunteers

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

April 30, 2026

Conditions

Healthy Volunteers

Interventions

DRUG

SEP-631

Oral, tablet

OTHER

Placebo

Oral, tablet

All Listed Sponsors

lead

Septerna, Inc.

INDUSTRY